ROR2 activation leads to downstream signaling via the Phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) axis, promoting survival signals and anchorage of MM cells within the BM. This evidence concerns the gene MTOR and Miyoshi myopathy.